As shown in Figure 6, a statistically significant effect of group in ESR1 mRNA expression was observed, with significant lower ESR1 gene expression in malignant tumors (Group M1–3) compared with normal/hyperplastic mammary tissues (Groups C) and benign CMTs (Group B) (p < 0.001). This evidence concerns the gene ESR1 and cancer.